Atavistik Bio Appoints Habib Dable to Board as Rare Hematology Pipeline Advances

Atavistik Bio has appointed biopharmaceutical executive Habib Dable to its board of directors, adding a veteran leader in drug development... Read More

The post Atavistik Bio Appoints Habib Dable to Board as Rare Hematology Pipeline Advances appeared first on citybiz.